Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide.
Document Type
Article
Publication Title
Bone marrow transplantation
DOI
10.1038/s41409-026-03082-x
Publication Date
10-29-2026
Recommended Citation
Im A, Wang T, DeFilipp Z, Farhadfar N, El Jurdi N, Khandelwal P, Kitko CL, Devos J, Castillo P, Ganguly S, Grunwald MR, Hamilton BK, Hashem H, Jamy O, Kharfan-Dabaja MA, Rangarajan HG, Yared JA, Williams KM, William BM, Spellman SR, Lee SJ, Pavletic SZ. Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide. Bone Marrow Transplant. 2026 Oct 29. doi: 10.1038/s41409-026-03082-x. Epub ahead of print. PMID: 42957810.